ProxsysRx Receives Equity Investment

ProxsysRx, a Birmingham, Ala.-based healthcare solutions company, received a growth equity investment from Atlanta-based Fulcrum Equity Partners with participation from members of the management team.

The amount of the deal was not disclosed. Fulcrum Partners Tom Greer and Jeff Muir lead the funding round and will join the company’s Board of Directors.

The funding will accelerate the company’s technological developments, expand the footprint of the organization to new markets around the United States, and provide additional infrastructure to support a larger company.

Led by CEO George B. Salem, ProxsysRx provides hospital and health system partners with technology-driven value, revenue, and savings through innovative administrative systems and pharmacy programs that increase patient engagement to achieve positive health outcomes.

Benefits to partners include readmission risk reduction, 340B savings, employee benefit cost savings, and improved patient satisfaction. ProxsysRx services for hospitals and health care systems include onsite retail pharmacy, 340B administration, personalized and digital patient engagement and management, and employee health benefit program management.



Join the discussion